Aminocaproic Acid Injection Market Report – Research, Industry Analysis Reports and Market Demands

Global Aminocaproic Acid Injection Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report

Buy now

Table of Content

1 Market Overview

1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
- 1.3.1 Overview: Global Aminocaproic Acid Injection Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 8ml
- 1.3.3 20ml
- 1.3.4 Other
1.4 Market Analysis by Application
- 1.4.1 Overview: Global Aminocaproic Acid Injection Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Other
1.5 Global Aminocaproic Acid Injection Market Size & Forecast
- 1.5.1 Global Aminocaproic Acid Injection Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Aminocaproic Acid Injection Sales Quantity (2021-2032)
- 1.5.3 Global Aminocaproic Acid Injection Average Price (2021-2032)

2 Manufacturers Profiles

3 Competitive Environment: Aminocaproic Acid Injection by Manufacturer

3.1 Global Aminocaproic Acid Injection Sales Quantity by Manufacturer (2021-2026)
3.2 Global Aminocaproic Acid Injection Revenue by Manufacturer (2021-2026)
3.3 Global Aminocaproic Acid Injection Average Price by Manufacturer (2021-2026)
3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Aminocaproic Acid Injection by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Aminocaproic Acid Injection Manufacturer Market Share in 2025
- 3.4.3 Top 6 Aminocaproic Acid Injection Manufacturer Market Share in 2025
3.5 Aminocaproic Acid Injection Market: Overall Company Footprint Analysis
- 3.5.1 Aminocaproic Acid Injection Market: Region Footprint
- 3.5.2 Aminocaproic Acid Injection Market: Company Product Type Footprint
- 3.5.3 Aminocaproic Acid Injection Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

4.1 Global Aminocaproic Acid Injection Market Size by Region
- 4.1.1 Global Aminocaproic Acid Injection Sales Quantity by Region (2021-2032)
- 4.1.2 Global Aminocaproic Acid Injection Consumption Value by Region (2021-2032)
- 4.1.3 Global Aminocaproic Acid Injection Average Price by Region (2021-2032)
4.2 North America Aminocaproic Acid Injection Consumption Value (2021-2032)
4.3 Europe Aminocaproic Acid Injection Consumption Value (2021-2032)
4.4 Asia-Pacific Aminocaproic Acid Injection Consumption Value (2021-2032)
4.5 South America Aminocaproic Acid Injection Consumption Value (2021-2032)
4.6 Middle East & Africa Aminocaproic Acid Injection Consumption Value (2021-2032)

5 Market Segment by Type

5.1 Global Aminocaproic Acid Injection Sales Quantity by Type (2021-2032)
5.2 Global Aminocaproic Acid Injection Consumption Value by Type (2021-2032)
5.3 Global Aminocaproic Acid Injection Average Price by Type (2021-2032)

6 Market Segment by Application

6.1 Global Aminocaproic Acid Injection Sales Quantity by Application (2021-2032)
6.2 Global Aminocaproic Acid Injection Consumption Value by Application (2021-2032)
6.3 Global Aminocaproic Acid Injection Average Price by Application (2021-2032)

7 North America

7.1 North America Aminocaproic Acid Injection Sales Quantity by Type (2021-2032)
7.2 North America Aminocaproic Acid Injection Sales Quantity by Application (2021-2032)
7.3 North America Aminocaproic Acid Injection Market Size by Country
- 7.3.1 North America Aminocaproic Acid Injection Sales Quantity by Country (2021-2032)
- 7.3.2 North America Aminocaproic Acid Injection Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

8.1 Europe Aminocaproic Acid Injection Sales Quantity by Type (2021-2032)
8.2 Europe Aminocaproic Acid Injection Sales Quantity by Application (2021-2032)
8.3 Europe Aminocaproic Acid Injection Market Size by Country
- 8.3.1 Europe Aminocaproic Acid Injection Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Aminocaproic Acid Injection Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

9.1 Asia-Pacific Aminocaproic Acid Injection Sales Quantity by Type (2021-2032)
9.2 Asia-Pacific Aminocaproic Acid Injection Sales Quantity by Application (2021-2032)
9.3 Asia-Pacific Aminocaproic Acid Injection Market Size by Region
- 9.3.1 Asia-Pacific Aminocaproic Acid Injection Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Aminocaproic Acid Injection Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

10.1 South America Aminocaproic Acid Injection Sales Quantity by Type (2021-2032)
10.2 South America Aminocaproic Acid Injection Sales Quantity by Application (2021-2032)
10.3 South America Aminocaproic Acid Injection Market Size by Country
- 10.3.1 South America Aminocaproic Acid Injection Sales Quantity by Country (2021-2032)
- 10.3.2 South America Aminocaproic Acid Injection Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

11.1 Middle East & Africa Aminocaproic Acid Injection Sales Quantity by Type (2021-2032)
11.2 Middle East & Africa Aminocaproic Acid Injection Sales Quantity by Application (2021-2032)
11.3 Middle East & Africa Aminocaproic Acid Injection Market Size by Country
- 11.3.1 Middle East & Africa Aminocaproic Acid Injection Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Aminocaproic Acid Injection Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

12.1 Aminocaproic Acid Injection Market Drivers
12.2 Aminocaproic Acid Injection Market Restraints
12.3 Aminocaproic Acid Injection Trends Analysis
12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

13.1 Raw Material of Aminocaproic Acid Injection and Key Manufacturers
13.2 Manufacturing Costs Percentage of Aminocaproic Acid Injection
13.3 Aminocaproic Acid Injection Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
14.2 Aminocaproic Acid Injection Typical Distributors
14.3 Aminocaproic Acid Injection Typical Customers

15 Research Findings and Conclusion

16 Appendix

16.1 Methodology
16.2 Research Process and Data Source

Description

According to our (Global Info Research) latest study, the global Aminocaproic Acid Injection market size was valued at US$ 115 million in 2025 and is forecast to a readjusted size of US$ 142 million by 2032 with a CAGR of 3.1% during review period.
Aminocaproic Acid Injection is an antifibrinolytic medication primarily used to treat or prevent bleeding caused by excessive fibrinolysis. It is effective in managing bleeding during or after surgical procedures, dental surgeries, and in patients with bleeding disorders such as hemophilia. By inhibiting plasminogen activation and stabilizing blood clots, this injection reduces the risk of hemorrhage. Administered intravenously, it is commonly used in clinical settings requiring rapid hemostatic action, including surgery, urology, ENT, and obstetrics and gynecology.
Aminocaproic acid injection has long served as a standard antifibrinolytic agent in surgical and trauma care, particularly in fields such as general surgery, urology, cardiothoracic surgery, obstetrics, and hematology. Globally, the market consists of both branded and generic products, dominated by manufacturers in North America, Europe, and Asia. As national healthcare systems increasingly incorporate hemostatic drugs into their coverage, hospital accessibility to the product has expanded. In developing countries, growing investments in healthcare infrastructure have led to a steady rise in demand for such essential perioperative medications.Looking ahead, the market is expected to experience steady growth, driven by increasing surgical volumes, expanding hospital capacity, and the standardization of perioperative bleeding management. In high-risk procedures such as cardiac or spinal surgery, reliance on antifibrinolytic therapies is deepening. Additionally, the drug's cost-effectiveness and proven role in minimizing blood loss and reducing transfusion requirements are making it more attractive to healthcare providers. As healthcare systems aim to optimize blood management strategies, this injection is likely to receive greater inclusion in treatment guidelines and institutional formularies.Key drivers include the growing global surgical population, aging demographics, rising awareness of postoperative recovery, and favorable reimbursement policies for hemostatic agents. However, the market also faces constraints. The drug's mature status and relatively low technical barrier have led to widespread generic competition and price pressure. In some regions, newer alternatives such as recombinant antifibrinolytics or monoclonal antibodies are gradually encroaching on its usage. Moreover, concerns over thrombotic risks associated with systemic antifibrinolytic use have led to cautious adoption in certain clinical contexts, potentially limiting further market expansion.
This report is a detailed and comprehensive analysis for global Aminocaproic Acid Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Aminocaproic Acid Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Aminocaproic Acid Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Aminocaproic Acid Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Aminocaproic Acid Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Aminocaproic Acid Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Aminocaproic Acid Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Daiichi Sankyo, Civica, Yangzhou Zhongbao Pharmaceutical, Chengdu Brilliant Pharmaceutical, Hunan Er-Kang Pharmaceutical, Changzhou Lanling Pharmaceutical, Baiao Pharmaceutical, Guangdong Wonterfull ITD Pharmaceutical, Jiangsu Yuexing Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Aminocaproic Acid Injection market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
8ml
20ml
Other
Market segment by Application
Hospital
Clinic
Other
Major players covered
Pfizer
Daiichi Sankyo
Civica
Yangzhou Zhongbao Pharmaceutical
Chengdu Brilliant Pharmaceutical
Hunan Er-Kang Pharmaceutical
Changzhou Lanling Pharmaceutical
Baiao Pharmaceutical
Guangdong Wonterfull ITD Pharmaceutical
Jiangsu Yuexing Pharmaceutical
Southwest Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Aminocaproic Acid Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Aminocaproic Acid Injection, with price, sales quantity, revenue, and global market share of Aminocaproic Acid Injection from 2021 to 2026.
Chapter 3, the Aminocaproic Acid Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Aminocaproic Acid Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Aminocaproic Acid Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Aminocaproic Acid Injection.
Chapter 14 and 15, to describe Aminocaproic Acid Injection sales channel, distributors, customers, research findings and conclusion.

Buy now